RxDoctor Payments Data

Christopher Grandfield, DPM

Foot & Ankle Surgery · la Porte, INNPI 1316054208

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,349 of the $2,941 with a category attached, or 79.9%. 14 manufacturers reported payments, led by Stryker at 58.4% of the total. Reporting peaked in 2019 at $1,661 and has fallen 68.9% since, to $517 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in IN, where the typical reported total is $4,256.

$2,941in general payments, 2019–2025

Across 74 payments — averaging $39.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Kerecis Limited$496
  • Organogenesis Inc.$210
  • Smith+Nephew$187
  • Johnson & Johnson$61
  • Hartmann USA, Inc.$58
  • plus $210 from 8 others

What the payments were for

  • Travel & lodging$56919%
  • Food & beverage$2,34980%
  • Education$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,941 in reported general payments places this provider in the 40th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana →

Medicare billing

Part B allowed, 2024
$152,457
Medicare patients
421
Services billed
1,491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin92$1,486
Duloxetine Hcl54$1,121
Terbinafine Hcl66$1,049
Doxycycline Hyclate26$551
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$492
Clindamycin Hcl28$286
Amitriptyline Hcl28$250
Methylprednisolone35$165
Allopurinol18$110
Meloxicam12$107

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in la Porte

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →